Safety of Chronic Cardiac Ryanodine Receptor Modulation: A 10-Year Experience-Reference-Cited by-同舟云学术

Safety of Chronic Cardiac Ryanodine Receptor Modulation: A 10-Year Experience

Published:2018-11 Issue:11 Volume:4 Page:1480-1481
ISSN:2405-500X
Container-title:JACC: Clinical Electrophysiology
language:en
Short-container-title:JACC: Clinical Electrophysiology

Author:

Bokhari Mahmoud M.,Spears Danna A.,Lai Patrick F.,Si Daoyuan,Billia Filio,Parker John D.,Al-Hesayen Abdul O.,Azam Mohammed A.,Riazi Sheila,Nanthakumar Kumaraswamy

Publisher

Elsevier BV

Reference5 articles.

1. Ca2+/calmodulin-dependent protein kinase II and protein kinase A differentially regulate sarcoplasmic reticulum Ca2+ leak in human cardiac pathology;Fischer;Circulation,2013

2. Dantrolene improves survival after ventricular fibrillation by mitigating impaired calcium handling in animal models;Zamiri;Circulation,2014

3. Calcium/calmodulin-dependent protein kinase II activity persists during chronic beta-adrenoceptor blockade in experimental and human heart failure;Dewenter;Circ Heart Fail,2017

4. Intracellular translocation of calmodulin and Ca2+/calmodulin-dependent protein kinase II during the development of hypertrophy in neonatal cardiomyocytes;Gangopadhyay;Biochem Biophys Res Commun,2010

5. Dantrolene, a therapeutic agent for malignant hyperthermia, markedly improves the function of failing cardiomyocytes by stabilizing inter-domain interactions within the ryanodine receptor;Kobayashi;J Am Coll Cardiol,2009

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Restoration of calcium release synchrony: A novel target for heart failure and ventricular arrhythmia;Heart Rhythm;2023-12

2. Modulation of Ryanodine Receptors Activity Alters the Course of Experimental Autoimmune Encephalomyelitis in Mice;Frontiers in Physiology;2021-12-17

3. Comment on “Overlapping Mechanisms of Exertional Heat Stroke and Malignant Hyperthermia: Evidence vs. Conjecture”;Sports Medicine;2021-10-09

4. Drug Repurposing Patent Applications April–June 2019;ASSAY and Drug Development Technologies;2020-04-01